Alembic Pharmaceuticals reports 36% rise in Q1 consolidated net profit

30 Jul 2018 Evaluate

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2018.

The company has reported over 2-fold jump in its net profit at Rs 113.98 crore for the quarter under review as compared to net profit of Rs 50.67 crore for the same quarter in the previous year. Total income of the company increased by 37.48% at Rs 811.58 crore for Q1FY19 as compared Rs 590.34 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 35.70% in its net profit at Rs 90.47 crore for the quarter under review as compared to Rs 66.67 crore for the same quarter in the previous year. Total consolidated income of the company increased by 33.05% at Rs 862.63 crore for Q1FY19 as compared Rs 648.36 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

926.00 -16.50 (-1.75%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.